Benziodarone
Chemical compound
- C01DX04 (WHO)
- 4-[(2-ethyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenol
- 68-90-6
N
- 6237
- 6001
Y
- 75CL65GTYR
- ChEMBL232201
Y
- DTXSID1046134
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
InChI
- InChI=1S/C17H12I2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3
Y
- Key:CZCHIEJNWPNBDE-UHFFFAOYSA-N
Y
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Benziodarone is a vasodilator.
![](http://upload.wikimedia.org/wikipedia/commons/thumb/9/97/Benziodaron_synthesis.svg/700px-Benziodaron_synthesis.svg.png)
- Bufeniode has the same aromatic substitution pattern.
See also
- Amiodarone
- Benzbromarone, the brominated analogue of benziodarone, used as an uricosuric
- Dronedarone
References
- Pizzichini M, Aleo MF, Marcolongo R, Marinello E (June 1982). "The mechanism of benzodiarone activity". Quaderni Sclavo di Diagnostica Clinica e di Laboratorio. 18 (2): 203–8. PMID 6984763.
- v
- t
- e
Vasodilators used in cardiac diseases (C01D)
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e